samedan logo
 
 
 
spacer
home > ebr > autumn 2018 > protein progression
PUBLICATIONS
European Biopharmaceutical Review

Protein Progression

Microarrays offer a well-established bioanalytical format for high-throughput studies of many different biomolecules. In the field of peptide and protein microarrays, great progress has been achieved in immobilising large numbers of native target molecules, such as recombinant human proteins or peptide libraries to microarray surfaces. With an increased content at high quality, protein and peptide microarrays offer new possibilities in proteomics and pharmaceutical R&D. Simultaneously, label-free sensing has evolved from highly sophisticated, but low-throughput, to powerful multiplexed screening tools. The combination of these advancements opens a new field of bioanalytics.

Analysis at a Glance

Proteins are involved in almost any process of a living cell. Therefore, proteomics is a key discipline of modern life sciences today. Furthermore, protein-protein interactions of human cells (the so-called human interactome, see Figure 1) and the interactions of proteins with other biomolecules are key for understanding any physiological process and manipulating it (eg, by a pharmaceutical or biopharmaceutical drug).

Protein scientists have developed different bioanalytical approaches based on proteins immobilised in a microarray format. Here, the focus lies on protein microarrays representing a set of species-specific (in most cases, human) proteins to study the binding of a specific molecule or sample to these target proteins in a single assay. The trend is towards a fraction up to the complete genetically encoded proteome.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Güenther Proll is Co-Founder and Managing Director at Biametrics and has more than 18 years’ experience in optical biosensing. Güenther’s work is focussed on the characterisation and development of optical transduction technologies, spatially resolved surface chemistry on diverse substrates, and multianalyte/multiplex assay developments. He holds a diploma in technical biology from the University of Stuttgart, Germany, and a PhD in physical chemistry from the University of Tuebingen, Germany.
spacer
Dr Güenther Proll
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera and Noble announce collaboration to support patients who self-administer medication

Nemera is excited to leverage the new collaboration to expand end-to- end offering of the parenteral franchise and increase patient onboarding through safer multi-use training devices
More info >>

White Papers

Time lapse photography to demonstrate the potential antimicrobial abilities of Dycem contamination control flooring

Dycem

A defined volume of bioluminescent reporter bacteria was deposited onto 20 mm x 20 mm coupons of Dycem flooring, vinyl tile and ITW Alma tacky mat. Through monitoring of bacterial bioluminescence, metabolic inhibition was observed on all three surfaces however the effect occurred more rapidly on Dycem flooring than on vinyl or ITW Alma. Recovery counts after three hours of exposure to the floor surfaces showed between a 65% and 100% decrease in the number of viable organisms recovered from Dycem flooring compared to controls. On vinyl and ITW Alma flooring, there were slight increases in the number of viable survivors recovered compared to controls. Dycem flooring inhibited the metabolic activity and reduced the number of viable survivors recovered of Salmonella enterica Serovar Typhimurium DT104 pGLITE. It remains unclear as to whether this effect is attributable to the impregnated biocide or rapid drying of the inoculum on this surface.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement